2025年5月期 第2四半期決算説明資料

This document is the financial results presentation for the second quarter of the fiscal year ending May 2025. The revenue reached 2,912 million yen, a 24.4% increase compared to the same period last year. However, the net loss attributable to parent shareholders was 17 million yen, primarily due to losses in the pre-disease and prevention platform segment. Operating profit decreased to 47 million yen, down 72.0% year-on-year. Moving forward, the company plans to strengthen existing businesses and invest in new ventures, aiming for profitability by the fiscal year ending May 2026. Overall, while performance is progressing well, losses in specific segments remain a challenge.